Dubai, UAE- Leading medical technology company Siemens Healthineers has announced the appointment of Vivek Kanade as the new Head for the company’s operations in the Middle East and Africa (MEA), effective from December 4, 2023. This decision aligns with the company’s strategy to unite its operations across the Middle East and the African continent, aiming to enhance its services to diverse healthcare providers and communities.

Vivek Kanade, a seasoned Siemens veteran with over thirty years of experience across various geographies and functions, previously served as the Head of Strategy for the company’s expansive Asia-Pacific Japan region. Before that, he held the position of Head at Siemens Healthineers for India, Bangladesh, Nepal, Sri Lanka, Bhutan, and the Maldives. During his tenure, Kanade co-chaired NatHealth in India, advising the Indian medical technology industry.

Commenting on the appointment, Vivek Kanade said: “As we strengthen our role as a trusted healthcare partner in this diverse growth region, this structural consolidation enables us to pool our strengths in following our core objectives, which include enhancing Access to Care and paving the way for better healthcare infrastructures in our markets. I am humbled and excited to start this new position, and look forward to uniting our strengths across the new zone and creating a positive difference in the lives of millions of patients across the Middle East and Africa.”

Kanade’s vision in his current capacity is to create a more significant impact on patients’ lives, increasing touchpoints and leveraging opportunities in economically challenging growth markets of Africa and the Middle East. A focal point of this vision is the Access to Care initiative, aimed at improving healthcare infrastructure, addressing the shortage of qualified staff, and ensuring healthcare provision for rural and underserved communities.

Also Read: Siemens Healthineers Bridges the Gap with Affordable Dual Source CT Scanner

“We aspire to create better outcomes and experiences for patients, no matter where they live by accelerating global development, building strategic partnerships, fighting the most threatening diseases, and rethinking the value chain,” added Kanade. “Specifically, we’re focusing on projects that are first and foremost scalable and fit our strategy while making an impact on local communities, by untapping new markets, capacity building and ensuring community reach.”